Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach
Authors:
Open Access
- 9 March 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (6) , 2959
Abstract
Tissue-specific gene methylation events are key to the pathogenesis of several diseases and can be utilized for diagnosis and monitoring. Here, we established an in silico pipeline to analyze high-throughput methylome datasets to identify specific methylation fingerprints in three pathological entities of major burden, i.e., breast cancer (BrCa), osteoarthritis (OA) and diabetes mellitus (DM). Differential methylation analysis was conducted to compare tissues/cells related to the pathology and different types of healthy tissues, revealing Differentially Methylated Genes (DMGs). Highly performing and low feature number biosignatures were built with automated machine learning, including: (1) a five-gene biosignature discriminating BrCa tissue from healthy tissues (AUC 0.987 and precision 0.987), (2) three equivalent OA cartilage-specific biosignatures containing four genes each (AUC 0.978 and precision 0.986) and (3) a four-gene pancreatic β-cell-specific biosignature (AUC 0.984 and precision 0.995). Next, the BrCa biosignature was validated using an independent ccfDNA dataset showing an AUC and precision of 1.000, verifying the biosignature’s applicability in liquid biopsy. Functional and protein interaction prediction analysis revealed that most DMGs identified are involved in pathways known to be related to the studied diseases or pointed to new ones. Overall, our data-driven approach contributes to the maximum exploitation of high-throughput methylome readings, helping to establish specific disease profiles to be applied in clinical practice and to understand human pathology.Keywords
Funding Information
- RESEARCH – CREATE – INNOVATE (T1EDK-00940)
This publication has 99 references indexed in Scilit:
- Allelic expression analysis of the osteoarthritis susceptibility gene COL11A1 in human joint tissuesBMC Musculoskeletal Disorders, 2013
- MMP13 is a critical target gene during the progression of osteoarthritisArthritis Research & Therapy, 2013
- The ConsensusPathDB interaction database: 2013 updateNucleic Acids Research, 2012
- Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patientsLife Sciences, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Prime suspect: the TCF7L2 gene and type 2 diabetes riskJournal of Clinical Investigation, 2007
- MATN3 (matrilin-3) sequence variation (pT303M) is a risk factor for osteoarthritis of the CMC1 joint of the hand, but not for knee osteoarthritisAnnals of the Rheumatic Diseases, 2007
- MTA1, a transcriptional activator of breast cancer amplified sequence 3Proceedings of the National Academy of Sciences, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002